Home/Filings/4/0001645572-18-000007
4//SEC Filing

Eyre Brik V 4

Accession 0001645572-18-000007

CIK 0000010456other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 5:43 PM ET

Size

12.5 KB

Accession

0001645572-18-000007

Insider Transaction Report

Form 4
Period: 2018-09-17
Eyre Brik V
CVP, Hospital Products
Transactions
  • Exercise/Conversion

    Common Stock, $1 par value

    2018-09-17$37.38/sh+42,243$1,579,043107,605 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-09-1742,2430 total
    Exercise: $37.38From: 2018-03-05Exp: 2025-03-03Common Stock, $1 par value (42,243 underlying)
  • Sale

    Common Stock, $1 par value

    2018-09-17$77.31/sh78,012$6,031,10858,993 total
  • Exercise/Conversion

    Common Stock, $1 par value

    2018-09-17$39.33/sh+29,400$1,156,302137,005 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-09-1729,40017,172 total
    Exercise: $39.33From: 2017-03-03Exp: 2026-03-03Common Stock, $1 par value (29,400 underlying)
Footnotes (2)
  • [F1]Transaction effected pursuant to a Rule 10b5-1 trading plan entered into on June 14, 2018 by Mr. Eyre with respect to certain vested stock options granted by Baxter International Inc. ("BII") to Mr. Eyre.
  • [F2]Price reflects weighted average sales price. Range of prices for transactions are $77.10 through $77.52. Full information regarding the number of shares sold at each separate price will be provided by BII upon request.

Issuer

BAXTER INTERNATIONAL INC

CIK 0000010456

Entity typeother

Related Parties

1
  • filerCIK 0001645572

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:43 PM ET
Size
12.5 KB